380.9902.30% ( +8.560 )
Closed: Oct 27, 16:00:00 (EDT)Current ValuationThe current P/E ratio is 44.78, within the reasonable range, cheaper than 30.65% of the time in the past 1 years, and the industry ranks 13/58, the industry Median -2.32.
44.78xP/E
$372.43Stock price
$8.32Earnings per share
44.78xP/E
Stock price$372.43Earnings per share$8.32
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 10.86x
- Typical range
- -12.12x–45.90x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
012243648
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
ILMNUSIllumina | 49.67x | 9.24% | $40.93B |
WSTUSWest Pharmaceutical | 49.18x | 26.29% | $27.78B |
BIOUSBio-Rad Lab | 44.78x | 70.13% | $9.96B |
BIOBBio-Rad Lab-B | 43.78x | -- | $9.74B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
